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Abstract
If insufficiently treated, Lyme borreliosis can evolve into an inflammatory disorder affecting skin, joints, and the CNS. Early
innate immunity may determine host responses targeting infection. Thus, we sought to characterize the immediate
cytokine storm associated with exposure of PBMC to moderate levels of live Borrelia burgdorferi. Since Th17 cytokines are
connected to host defense against extracellular bacteria, we focused on interleukin (IL)-17 and IL-22. Here, we report that,
despite induction of inflammatory cytokines including IL-23, IL-17 remained barely detectable in response to B. burgdorferi.
In contrast, T cell-dependent expression of IL-22 became evident within 10 h of exposure to the spirochetes. This dichotomy
was unrelated to interferon-c but to a large part dependent on caspase-1 and IL-1 bioactivity derived from monocytes. In
fact, IL-1b as a single stimulus induced IL-22 but not IL-17. Neutrophils display antibacterial activity against B. burgdorferi,
particularly when opsonized by antibodies. Since neutrophilic inflammation, indicative of IL-17 bioactivity, is scarcely
observed in Erythema migrans, a manifestation of skin inflammation after infection, protective and antibacterial properties
of IL-22 may close this gap and serve essential functions in the initial phase of spirochete infection.
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Introduction
Interleukin (IL)-22, along with IL-17, is principally recognized
as decisive component of Th17-like immune responses in humans
and mice [1–7]. Beyond that, Th1 and distinct NK cell subsets
have been identified as relevant sources of IL-22 [1,2,8]. Due to
restricted expression of IL-22RI, this cytokine characteristically
affects almost exclusively the non-leukocytic cell compartment, in
particular hepatocytes, synoviocytes, and cells of epithelial origin
such as keratinocytes and colonocytes. Being a member of the IL-
10 cytokine family, activation of the signal transducer and
activator of transcription (STAT) pathway, foremost STAT3,
obviously plays a pivotal role for IL-22 immunomodulatory and
tissue-protective properties [1,2]. Enhanced IL-22 levels have been
linked to various states of immunoactivation as seen in the context
of infection [9–12], autoimmunity [13,14], and allergic disorders
[6]. However, the role of IL-22 in disease is not unambiguous but
apparently depends on the pathophysiological context. Specifical-
ly, IL-22 ameliorated disease in selected models of microbe/
infection-driven inflammation at host/environment interfaces
[9,10,15,16]. This property likely relates to upregulation of anti-
microbial proteins such as b-defensins, regIII proteins and
lipocalin-2 [1,9,10], of anti-bacterial inducible nitric oxide
synthase (iNOS) [17], and to enhanced mucus production under
the influence of IL-22 [15]. In contrast, data in the context of
psoriasis [18,19] and arthritis [13] suggest a pathogenic function of
this cytokine. Notably, those latter inflammatory diseases are not
primarily infection-driven but linked to autoimmunity and tissue
hyperplasia.
Recent research efforts aiming to further understand the
function of specific T cell subsets in shaping immune responses
revealed considerable plasticity and species specificity concerning
the development and fate of Th17 cells and their profile of
cytokine production. Not only has now been widely appreciated
that a considerable proportion of IL-17
+ Th17 cells also expresses
the Th1 signature cytokine interferon (IFN)-c [4,6,20–22].
Moreover, IL-22
+ IL-17
- T cells that do not fit the Th1/Th2/
Th17 classification were recently introduced. These T cells have
lately been coined Th22 or T22, though further characterization
of those recent subsets appears crucial [23–27].
Lyme borreliosis, the most common vector-borne disease in the
United States and Europe, is characterized by multifaceted clinical
PLoS Pathogens | www.plospathogens.org 1 October 2010 | Volume 6 | Issue 10 | e1001144manifestations caused by spirochetes of the Borrelia burgdorferi sensu
latocomplex, inparticular B. afzelii, B.garinii,B.spielmanii,B.bavariensis,
and B. burgdorferi. If left insufficiently- or untreated, infection may
proceed to cutaneous manifestations, carditis, neuroborreliosis, or
Lyme arthritis, representing an array of most relevant and severe
inflammatory complications of chronic infection [28,29]. The
pattern of early cytokine production not only may determine initial
flu-like symptoms as seen in a number of these patients but also
dissemination and hence course of disease in Lyme borreliosis
[30,31]. By using human peripheral blood mononuclear cells
(PBMC), a culture model of reasonably manipulated primary
leukocytic cells, we set out to characterize herein the cytokine storm
initiated by exposure to moderate levels of B. burgdorferi for up to
65h. Since Th17-like immune responses have been connected in
particulartohost defenseagainst extracellularbacteria [4],we chose
to focus on expression of IL-17 and IL-22.
Results
A specific cytokine pattern associated with PBMC
exposed to live B. burgdorferi
Here, we sought to investigate in detail initial cytokine
production by PBMC in response to live B. burgdorferi. Protein
profiling by antibody array analysis indicated a distinct pattern of
cytokine secretion by PBMC under the influence of live
spirochetes. Specifically, we confirm previous observations on
activation of prototypic pro-inflammatory cytokines such as IL-1b,
tumor necrosis factor (TNF)-a, IL-6, and IFNc [32–34].
Moreover, we report for the first time on secretion of IL-12 and
IL-23 from PBMC activated by live B. burgdorferi (Fig. 1A). An
array overview and a semiquantitative analysis of cytokine
profiling shown in Figure 1A is provided in supplementary data
(Fig. S1 and S2). Array data on B. burgdorferi-induced secretion of
TNFa (Fig. 1BC), IL-1b (Fig. 1D), IL-23 (Fig. 1E), IL-12
(Fig. 1F), and IFNc (Fig. 1G) were confirmed by independent sets
of experiments and ELISA analysis. Unless otherwise indicated, in
the current study we chose to expose PBMC to highly viable and
motile B. burgdorferi cells at a MOI of 0.1. This low 1/10 (B.
burgdorferi/PBMC) ratio was specifically selected because at this
MOI the spirochete is not supposed to induce cell death in either
monocytes or T cells [33]. This also allows prolonged incubation
periods for analysis of cytokines that are induced more slowly or
are dependent on activation of intermediate cell types.
IL-8 upregulation did not show up in array analysis which was
due to common background expression of IL-8 in freshly-isolated
PBMC [35] and analysis under saturating assay conditions. Yet,
ELISA analysis (Fig. 1H) confirmed IL-8 induction by B.
burgdorferi [34,36,37] which was not affected by coincubation with
polymyxin B (PmxB). The latter observation agrees with absence
of LPS in Borreliae and clearly excludes LPS as stimulatory
component in the cellular model used herein. Array analysis also
confirmed previous data on basal production of IL-1Ra [38],
macrophage migration inhibitory factor (MIF) [39], and interfer-
on-inducible protein-10 (IP-10) [40] by PBMC which over time
(65 h incubation period) obviously precluded (semi)-quantitative
evaluation of those three parameters under the current assay
conditions (Fig. S2).
Most notably, array analysis also identified a set of cytokines
that (at a MOI of 0.1) remained at undetectable levels despite
strong activation of PBMC. This group of cytokines included IL-2,
IL-4, IL-10, IL-13, and most remarkably IL-17A (denoted as
IL-17 throughout this manuscript) as well as IL-17E (Fig. 1A).
Lack of upregulation of IL-2 (5.9 pg/ml61.5 pg/ml versus
2.6 pg/ml61.3 pg/ml for control versus B. burgdorferi 297,
MOI=30, 65 h incubation, n=5) and IL-17 (7.1 pg/ml6
2.2 pg/ml versus 8.8 pg/ml63.0 pg/ml for control versus B.
burgdorferi 297, MOI=30, 65 h incubation, n=5) was unmistak-
ably confirmed by ELISA analysis of additional independent
experiments with a MOI of up to 30. In addition, secretion of IL-
18 was also assessed by ELISA. Fig. 1I demonstrates only modest
IL-18 secretion in response to B. burgdorferi, an observation in
striking contrast to stunning secretion of IL-1b in those same
experiments (Fig. 1D).
Early production of IL-22 but not of IL-17 by PBMC
exposed to live B. burgdorferi
Array analysis revealed lack of immediate IL-17 production by
PBMC in response to live B. burgdorferi. Hence, production of IL-
22, a cytokine not covered by the antibody array used herein but
usually produced in conjunction with IL-17 in Th17-like
responses, was assessed under these same conditions. Surprisingly,
ELISA analysis proved robust IL-22 induction by B. burgdorferi 297.
Detailed analysis suggested optimal IL-22 secretion at the low
MOI of 0.1. No induction of either IL-17 or IL-17F was detectable
in these same experiments (Fig. 2A). Time-course analysis
furthermore revealed strong and immediate induction of IL-22
mRNA that reached maximal levels within the first 24 h of
exposure to B. burgdorferi 297 as detected by real-time PCR
(Fig. 2B) and standard PCR analysis (Fig. 2B, inset),
respectively. In fact, significant expression of IL-22 was detectable
by real-time PCR as early as 10 h after onset of exposure of cells to
B. burgdorferi 297 at a MOI of 0.1 (397.5-fold induction
compared to unstimulated control, n=3, p,0.05). IL-22 mRNA
translated well into protein release that was most pronounced
between 24 h–48 h of stimulation (Fig. 2C). The latter data agree
with steady TNFa secretion over time (Fig. 1C) and altogether
concure with lack of B. burgdorferi-mediated cytotoxicity at the low
MOI of 0.1. No induction of IL-17 was detectable in these same
time-course experiments at any data point of the 65 h incubation
period. Levels of IL-17 always remained below 40 pg/ml in
Author Summary
Lyme borreliosis displays multifaceted clinical manifesta-
tions caused by the Borrelia burgdorferi sensu lato complex.
If insufficiently treated, infection may proceed to inflam-
matory complications of chronic infection. Th17-like
cytokines, foremost IL-17 and IL-22, are crucial for host
defense against extracellular bacteria. IL-17/IL-22 secretion
by human leukocytes exposed to live Borreliae has not
been analyzed. Here we report that B. burgdorferi-activated
PBMC lack immediate IL-17 expression despite being
highly activated and robust T cell-dependent production
of IL-22 that to a large part is mediated by monocyte-
derived IL-1. Early innate immunity may shape dermal
infection, thus likely affecting bacterial dissemination.
Specifically, insufficient neutrophil recruitment/function,
supposedly due to insufficient early IL-17 production along
with a lack of opsonizing antibodies, may favor the spread
of B. burgdorferi. Indeed, neutrophilic inflammation,
indicative of IL-17 bioactivity, is scarcely observed in
Erythema migrans, a manifestation of skin inflammation
after infection. Production of IL-22 may fill this gap.
Current knowledge on the role of IL-22 in epithelial
biology in fact supports the hypothesis that IL-22 may
serve as protection, particularly under conditions of
inadequate neutrophil-driven host defense as seen early
in B. burgdorferi infection.
IL-22 Induced by Live B. burgdorferi
PLoS Pathogens | www.plospathogens.org 2 October 2010 | Volume 6 | Issue 10 | e1001144Figure 1. A specific cytokine pattern associated with PBMC exposed to live B. burgdorferi. (A) PBMC were either kept as unstimulated
control or exposed to B. burgdorferi 297 (MOI=0.1). After 65 h cell-free cell culture supernatants were analyzed in a 1:3 dilution by antibody array
analysis. One representative of two independently performed experiments (two different donors) is shown. (B) PBMC were either kept as
unstimulated control or exposed to the indicated MOI of B. burgdorferi 297. After 65 h, TNFa release was determined by ELISA. Data are expressed as
means 6 SEM (n=6 for unstimulated control and MOI=0.1, n=3 for MOI=1 and 3); **p,0.01, ***p,0.001 compared with unstimulated control; raw
data were analyzed by one-way ANOVA with post hoc Bonferroni correction. (C) PBMC were either kept as unstimulated control or were exposed to B.
burgdorferi 297 (MOI=0.1). After the indicated time periods TNFa release was determined by ELISA. Data are expressed as means 6 SEM (n=3);
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burgdorferi 297 (data not shown). Since levels of IL-22 mRNA in
unstimulated PBMC are extremely low, their upregulation in
response to Borreliae was likely driven by gene promoter activation.
To test this hypothesis a 1.230 bp human IL-22 promoter
fragment was cloned into pGL3 and used for analysis of promoter
activation by luciferase reporter assays. For that purpose
conditioned media of either unstimulated (control conditioned
medium, CCM) or B. burgdorferi-stimulated PBMC were generated
and analyzed for their capability to amplify IL-22 promoter
activity in the cellular context of aCD3-stimulated Jurkat T cells.
Luciferase reporter assays shown in Fig. 2D demonstrate that
conditioned media from PBMC exposed to spirochetes were in
fact able to dose-dependently enhance IL-22 promoter activity.
Moreover, conditioned media derived from PBMC exposed to B.
burgdorferi at the high MOI of 10 significantly induced IL-22
promoter activity even in the absence of aCD3 stimulation
(Fig. 2E). Strong inhibition of IL-22 production by coincubation
of PBMC with IL-10 (Fig. 2F) or dexamethasone (Fig. 2G), both
agents known for their pronounced monocyte deactivation
potential, suggests that IL-22 secretion is largely dependent on
prototypic pro-inflammatory signaling pathways. Induction of IL-
22 was not restricted to B. burgdorferi 297 but was also seen in
response to other spirochetes of the B. burgdorferi sensu lato complex.
In contrast, all spirochetes tested were unable to mediate
production of IL-17 (Tab. 1). Lack of IL-17 secretion by B.
burgdorferi-activated PBMC was not related to a general incapacity
of cultivated PBMC to rapidly produce IL-17. In fact, we confirm
a previous report [22] on the ability of IL-2 to upregulate IL-17
release by PBMC (data not shown). Accordingly, the combination
IL-2/IL-23 mediated significant secretion of IL-17 (Fig. 2H).
Lack of IL-17 secretion by PBMC as detected herein was
furthermore unrelated to a potential regulatory effect of IFNc
on immunoactivation and Th17-like cytokine responses [5,41,42].
In fact, coincubation with an IFNc neutralizing antibody did not
install IL-17 release by B. burgdorferi-stimulated PBMC (data not
shown). In contrast to IL-17, production of IL-10 increased with
increasing dosage of B. burgdorferi (Fig. 2I), which agrees with
previous observations [34]. In fact, induction of IL-10 may relate
to the tendency of reduced release of IL-22 (Fig. 2A) and TNFa
(data not shown) after exposure of PBMC to high concentrations
of live B. burgdorferi.
IL-1 drives production of IL-22 by PBMC
Although a fully consistent picture on mechanisms mediating
human Th17 development is lacking, a pivotal role for IL-1 is
currently emerging [4,6,21,43,44]. Notably, IL-1b was among the
genes most prominently induced by live B. burgdorferi in PBMC
(Fig. 1AD). Therefore, we set out to determine the contribution of
IL-1 to IL-22 expression under the influence of spirochetes. For
that purpose the pharmacological strategies of IL-1 receptor
blockage using IL-1 receptor antagonist (IL-1Ra) and of caspase-1
inhibition were pursuit [45]. As shown in Fig. 3A, coincubation
with IL-1Ra was able to significantly impair IL-22 secretion by
PBMC indicating a role for endogenously produced IL-1 in the
IL-22 response initiated by B. burgdorferi. This conclusion concurs
with the capability of Ac-YVAD-CHO, a specific inhibitor of
caspase-1, to significantly decrease IL-22 release from PBMC
(Fig. 3B). Interestingly, IL-1b, used as single stimulus, was capable
of mediating IL-22 but not IL-17 production by PBMC (Fig. 3C).
Notably, IL-1Ra (1.3 mg/ml) did not affect IL-22 promoter
activation as detected in the aforementioned Jurkat T cell protocol
using conditioned media from PBMC exposed to B. burgdorferi as
stimulus, irrespective of the presence or absence of aCD3
stimulation (data not shown). This observation is consistent with
previous reports demonstrating that Jurkat T cells, in contrast to
primary T cells, insufficiently respond to IL-1 due to scarce IL-1
receptor expression [46,47]. Therefore, IL-22 promoter induction
as shown in Fig. 2DE obviously reflects the IL-1 independent
proportion of IL-22 gene activation which became evident in
PBMC under the influence of IL-1Ra or Ac-YVAD-CHO
(Fig. 3AB). As opposed to IL-1b, TNFa, used as single stimulus,
was unable to stimulate secretion of IL-22 by PBMC (3.8 pg/ml
61.7 pg/ml versus 11.8 pg/ml66.1 pg/ml for control versus TNFa
(50 ng/ml), 65 h incubation, n=5).
T cell- and monocyte-dependent production of IL-22 by
PBMC exposed to live B. burgdorferi
In order to further track down cellular sources of IL-22,
subpopulations known to be capable of producing this cytokine
were depleted from the mixed leukocytic population of PBMC
before exposure to B. burgdorferi. For that purpose either cells
expressing CD3 (mainly being T cells) or CD56 (mainly being NK
cells) were targeted in a first set of experiments. Fig. 4 shows
representative results from CD3 (A) and CD56 (B) depletion
experiments. Notably, CD3
+ T cells were depleted by
85.2%63.2% (n=5) and CD56
+ cells were depleted by
85.1%61.8% (n=8) from the total lymphocyte population of
PBMC. In accord with previous observations [48–50],
4.7%61.0% (n=8) of lymphocytes belonged to the minor
population of CD3
+/CD56
+ cells that includes the population of
NKT cells. This CD3
+/CD56
+ cell population was reduced by
95.4%61.0% (n=8) after CD56 depletion. After the depletion
procedure, equal numbers of regular PBMC or depleted cell
populations were exposed to B. burgdorferi 297 and production of
IL-22 and IFNc was evaluated. Notably, T cell depletion (CD3
+)
from PBMC suppressed production of IL-22 in response to
spirochetes down to background levels whereas IFNc production
was not significantly affected (Fig. 4C). In contrast, depletion of
NK and NKT cells (CD56
+) resulted in remarkable impairment of
IFNc production. This observation agrees with the previously
reported dominant role of NK cells for IFNc production by B.
burgdorferi-stimulated PBMC [51] and furthermore emphasizes the
crucial role of this cell type for initiation of inflammatory processes
in the context of infections [52]. Notably, a clear tendency towards
enhanced IL-22 secretion became apparent under those condi-
tions, an observation that may in addition indicate a functional
role of regulatory NK cells [53] producing modulatory factors like
TGFb [54] capable of restraining IL-1 [45] and IL-22 [26]
production (Fig. 4D). Compared to untreated PBMC, treatment
**p,0.01, compared with unstimulated control at the respective time point; raw data were analyzed by unpaired Student’s t-test. (D-I) PBMC were
either kept as unstimulated control or were exposed to B. burgdorferi 297 (MOI=0.1). After 24 h (D-G, I) or 65 h (H), release of IL-1b (D; n=3; *p,0.05,
compared with unstimulated control), IL-23 (E; n=3; *p,0.05, compared with unstimulated control), IL-12 (F; n=5; ***p,0.001, compared with
unstimulated control), IFNc (G; n=3; ***p,0.001, compared with unstimulated control), IL-8 (H; n=5; ***p,0.001, compared with unstimulated
control; where indicated experiments were performed in the presence of PmxB at 3 mg/ml), and IL-18 (I; n=3; *p,0.05, compared with unstimulated
control) was determined by ELISA. Raw data were either analyzed by unpaired Student’s t-test (D-G, I) or by one-way ANOVA with post hoc Bonferroni
correction (H).
doi:10.1371/journal.ppat.1001144.g001
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PLoS Pathogens | www.plospathogens.org 4 October 2010 | Volume 6 | Issue 10 | e1001144Figure 2. Production of IL-22 but not of IL-17 by PBMC exposed to live B. burgdorferi. (A) PBMC were either kept as unstimulated control or
exposed to the indicated MOI of B. burgdorferi 297. After 65 h, IL-22 (closed triangles), IL-17 (closed circles), and IL-17F (open circles) release was
determined by ELISA. Data are expressed as means 6 SEM (n=10); **p,0.01, compared with unstimulated control; raw data were analyzed by one-
way ANOVA with post hoc Bonferroni correction. (B) PBMC were either kept as unstimulated control or were exposed to B. burgdorferi 297 (MOI=0.1).
After the indicated incubation periods, total RNA was isolated and IL-22 mRNA expression was determined by real-time PCR analysis. IL-22 mRNA was
normalized to that of GAPDH and is shown as mean fold induction compared to unstimulated control (at the respective time point) 6 SEM (n=3);
*p,0.05, **p,0.01, ***p,0.001 compared with unstimulated control (at the respective time point); raw data were analyzed by unpaired Student’s t-
test. Inset: In addition to real-time PCR, data from one representative experiment was analyzed by standard PCR analysis. (C) PBMC were either kept as
unstimulated control or were exposed to B. burgdorferi 297 (MOI=0.1). After the indicated time periods IL-22 release was determined by ELISA. Data
are expressed as means 6 SEM (n=5); **p,0.01, ***p,0.001 compared with unstimulated control at the respective time point; raw data were
analyzed by unpaired Student’s t-test. (D) Jurkat T cells were transfected for 5 h with pGL3-IL22 together with Renilla luciferase as described in the
materials and methods section. After 15 h of rest, cells were resuspended in control conditioned media (CCM) obtained from unstimulated PBMC or in
conditioned media from PBMC exposed to B. burgdorferi 297 (either MOI=0.1 (n=3) or MOI=10 (n=6), stimulation period: 15 h) and stimulated with
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Borrelia) did not affect IL-22 or IFNc production (data not shown).
To further investigate T cell-dependent IL-22 production,
CD4
+ and CD8
+ T cells were depleted from PBMC. Fig. 5 shows
representative results from CD4
+ (A) and CD8
+ (B) depletion
experiments. Notably, CD4
+ T cells were depleted by
96.9%61.2% (n=3) and CD8
+ cells were depleted by
84.8%63.7% (n=3) from the total lymphocyte population of
PBMC. After the depletion procedure, equal numbers of regular
PBMC or depleted cell populations were exposed to B. burgdorferi
297 and production of IL-22 was evaluated. Notably, CD4
+ or
CD8
+ T cell depletion significantly reduced production of IL-22
by 88.5% and 44.9%, respectively (Fig. 5C). Compared to
untreated PBMC, treatment with either CD4
+ or CD8
+ microbe-
ads (without further exposure to Borrelia) did not affect IL-22
production (Fig. 5C). Notably, PCR analysis of CD4
+ and CD8
+
T cells isolated from PBMC after exposure to B. burgdorferi 297
revealed IL-22 expression in both T cell subsets (Fig. 5D). In light
of the aforementioned CD3 and CD56 depletion experiments
these data altogether suggest that production of IL-22 by B.
burgdorferi-stimulated PBMC is achieved by the CD3
+ T cell
compartment.
Finally, we assessed whether IL-22 production by CD3
+ T cells
is dependent on the presence of CD14
+ monocytes in B. burgdorferi-
stimulated PBMC. Fig. 6A displays a representative CD14
depletion experiment. CD14
+ cells were on average depleted by
96.8%63.2% (n=5) from the total population of PBMC. In fact,
CD14
+ cell depletion was associated with complete suppression of
IL-1b production in the context of stimulation by B. burgdorferi
(Fig. 6B), an observation in full agreement with monocytes being
the major producers of IL-1b in PBMC. Fig. 6C also displays
reduced secretion of IFNc by the CD14
+ depleted PBMC fraction.
This tendency, likely based on weakened IL-12 production under
those conditions, did however not reach statistical significance in
the set of experiments performed. IL-12 in fact plays a crucial role
for IFNc production by NK cells [52]. Most notably, CD14
depletion of PBMC significantly impaired B. burgdorferi-mediated
IL-22 production (Fig. 6D). Compared to untreated PBMC,
treatment with CD14 microbeads (without further exposure to
Borrelia) did not affect cytokine production (data not shown). The
conclusion that IL-22 production by T cells as detected herein is
dependent on activation of intermediate cell types, in particular
monocytes, is furthermore emphasized by lack of significant IL-22
release from highly purified CD3
+ T cells exposed to live B.
burgdorferi (29.6 pg/ml66.9 pg/ml versus 25.9 pg/ml66.2 pg/ml
for unstimulated CD3
+ T cells versus CD3
+ T cells exposed to B.
burgdorferi for 65h at a MOI of 0.1; n=6). In addition, the TLR5
ligand flagellin, a known strong activator of human PBMC [55]
that is expressed by B. burgdorferi, activated IL-22 secretion in
PBMC [56] but not in highly purified T cells (data not shown).
A recent report, unrelated to spirochetes, demonstrates that also
plasmacytoid dendritic cells (pDC) have the capability to support
IL-22 production by isolated T cells activated with PMA/
ionomycin [23]. To assess whether pDC may contribute to IL-
22 production under the current experimental conditions, PBMC
were activated by incubation with standard CpG oligonucleotides
(type A and C) and production of IL-22 and IFNa was
determined. Notably, pDC are the chief cell type in PBMC
expressing TLR9. Engagement of the TLR9 signaling pathway by
suitable CpG motifs results in efficient generation of IFNa,a
common readout for pDC activation [57]. Fig. 7 clearly
demonstrates that exposure of PBMC to the CpG oligonucleotides
did not mediate IL-22 production (AB, left column), despite
induction of IFNa (AB, right column). Moreover, activation of
the TLR9/CpG signaling axis did not enhance IL-22 release from
PBMC stimulated by B. burgdorferi. Unexpectedly, CpG
oligonucleotides significantly reduced IL-22 production under
those conditions (AB, left column). As expected, B. burgdorferi
mediated robust IL-22 production in those same experiments. At
variance with a recent report [58] we did not observe production
of IFNa under the influence of B. burgdorferi which likely reflects
aCD3 (25 mg/ml) thereafter. After another 8 h, cells were harvested and luciferase assays were performed. Data are expressed as promoter activity (%
of aCD3 at CCM 6 SD); **p,0.01, ***p,0.001 compared with aCD3 at CCM;
#p,0.05,
###p,0.001 compared with Jurkat T cells in CCM in the
absence of aCD3 and B. burgdorferi. Raw data were analyzed by one-way ANOVA with post hoc Bonferroni correction. (E) Jurkat T cells were treated
using the protocol described under (D). However, only B. burgdorferi at a MOI of 10 were used to generate PBMC-derived conditioned media. In
addition, aCD3 stimulation of Jurkat T cells was omitted. Data are expressed as promoter activity (% of CCM 6 SD) (n=8); ***p,0.001 compared with
promoter activity at CCM. Raw data were analyzed by unpaired Student’s t-test. (FG) PBMC were exposed to B. burgdorferi 297 (MOI=0.1) either alone
or in combination with the indicated concentrations of IL-10 (F) or dexamethasone (G). After 65 h, IL-22 release was determined by ELISA. Data (% of
B. burgdorferi alone) are expressed as means 6 SEM (IL-10: n=6, dexamethasone: n=3); closed circles denote unstimulated control, closed squares
denote IL-10 at 20 ng/ml (F) or dexamethasone at 50 nM (G) alone; **p,0.01 compared with unstimulated control;
#p,0.05,
##p,0.01 compared
with PBMC exposed to B. burgdorferi 297 alone; raw data were analyzed by one-way ANOVA with post hoc Bonferroni correction. (H) PBMC were
either kept as unstimulated control or stimulated with IL-2 (20 ng/ml)/IL-23 (20 ng/ml) or were exposed to B. burgdorferi 297 (MOI=0.1). After 65 h,
IL-17 release was determined by ELISA. Data are expressed as means 6 SEM (n=15 for control and IL-2/IL-23, n=8 for B. burgdorferi 297); n.s. denotes
not significantly different from unstimulated control; ***p,0.001, compared with unstimulated control,
##p,0.01 compared with IL-2/IL-23; raw
data were analyzed by one-way ANOVA with post hoc Bonferroni correction. (I) PBMC were either kept as unstimulated control or were exposed to
the indicated dosages of B. burgdorferi 297. After 42 h, IL-10 release was determined by ELISA. Data are expressed as means 6 SEM (n=8 for control
and B. burgdorferi 297 at a MOI of 0.1, n=6 for B. burgdorferi 297 at a MOI of 10); n.s. denotes not significantly different from unstimulated control;
**p,0.01, compared with unstimulated control; raw data were analyzed by one-way ANOVA with post hoc Bonferroni correction.
doi:10.1371/journal.ppat.1001144.g002
Table 1. IL-22 and IL-17 production by PBMC exposed to
different Borrelia species.
Strain IL-22 (pg/ml)
IL-17 (pg/ml)
n=4
Control 31.6±19.5 (n=10) 5.7±4.4
297 (B. burgdorferi; CSF isolate) 1605.0±703.9 * (n=10) 11.1±6.4
A14S (B. spielmanii; skin isolate) 2329.4±954.6 * (n=7) 16.8±9.9
G1 (B. garinii; CSF isolate) 821.7±277.5 * (n=10) 6.6±4.0
MT-M8 (B. lusitaniae; tick isolate) 881.5±187.5 ** (n=5) 0.4±0.4
PBi (B. bavariensis; CSF isolate) 1032.8±246.8 ** (n=5) 0.3±0.3
FEM-1 D15 (B. afzelii; skin isolate,
clonal)
890.9±167.7 *** (n=5) 2.7±1.2
IL-22 and IL-17 production by PBMC exposed to different Borrelia species, B.
bavariensis not yet validated (MOI=0.1; 48 h incubation; data are expressed as
means 6 SEM;
*p,0.05, **p,0.01, ***p,0.001 versus control; raw data were analyzed by
Student’s t-test with Borrelia exposure compared to the unstimulated control of
the respective set of experiments).
doi:10.1371/journal.ppat.1001144.t001
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study (AB, right column).
Detection of IL-22 in erythema migrans patients
In order to relate induction of IL-22 to the pathophysiology of
erythema migrans, immunohistochemical analysis was performed. For
that purpose skin biopsies obtained from 12 patients with the
diagnosis of erythema chronicum migrans were examined for expression
of IL-22 protein. Biopsy specimens were taken a few weeks after the
initial tick bite. In fact, IL-22 positive cells were detected throughout
the specimens with variable degree. Abundant IL-22 was evident in
7/12 biopsy specimens. Fig. 8 displays two selected skin biopsies
from two different patients of this group. Staining was absent upon
omission of the first anti-IL-22 antibody,which servedas an internal
control (data not shown). In the current study we were unable to
provide data on IL-22 expression in normal healthy skin. However,
previous observations demonstrate that IL-22 expression in normal
healthy skin is barely detectably on mRNA (realtime PCR) or
protein (immunohistochemistry) level, respectively [18,59].
Discussion
In the current study focussing on the human system the fairly
unmanipulated mixed cell population of PBMC was used to
analyze production of cytokines in the initial phase of leukocyte
exposure to live B. burgdorferi. In accord with previous reports [34],
a pro-inflammatory response with robust expression of key
parameters such as IL-1b, TNFa, IL-12, and IFNc was detected.
However, thorough analysis likewise indicated that cytokine
production not merely reflected a broad cytokine storm initiated
by overwhelming innate immunity [60,61] but actually displayed
specificity. Despite being highly activated, PBMC failed to
generate IL-2 and most notably IL-17, even after exposure to
high concentrations of B. burgdorferi 297 (MOI=30) for 65 h. Lack
of immediate IL-17 production, besides IL-17A also IL-17E and
IL-17F, was evident despite abundant production of IL-1b and IL-
23, both regarded as pivotal factors of human Th17 development
[6,20,21]. In contrast, activation of PBMC by IL-2/IL-23 resulted
in significant IL-17 induction. Furthermore, IL-10 was not
induced at a MOI of 0.1, the concentration rountinely used for
Figure 3. IL-1 drives production of IL-22 by PBMC exposed to live B. burgdorferi. (A) PBMC were kept as unstimulated control or cultivated
together with IL-1Ra (1.3 mg/ml) in the presence or absence of B. burgdorferi 297 (MOI=0.1). After 65 h, IL-22 release was determined by ELISA. Data
are expressed as means 6 SEM (n=5); **p,0.01 compared with unstimulated control,
#p,0.05 compared with B. burgdorferi 297/IL-1Ra. (B) PBMC
were kept as unstimulated control or cultivated together with Ac-YVAD-CHO (50 mM) in the presence or absence of B. burgdorferi 297 (MOI=0.1).
After 48 h, IL-22 release was determined by ELISA. Data are expressed as means 6 SEM (n=12); ***p,0.001 compared with unstimulated control,
#p,0.05 compared with B. burgdorferi 297/Ac-YVAD-CHO. (AB) IL-1Ra and Ac-YVAD-CHO were added to the cultures 0.5 h before exposure of PBMC
to B. burgdorferi. (C) PBMC were either kept as unstimulated control or stimulated with IL-1b (50 ng/ml). After 65 h, IL-22 (black bars) and IL-17 (grey
bars) release was determined by ELISA. Data are expressed as means 6 SEM (n=7); **p,0.01, compared with unstimulated control,
##p,0.01
compared with IL-17 levels in the presence of IL-1b. (ABC) Raw data were analyzed by one-way ANOVA with post hoc Bonferroni correction.
doi:10.1371/journal.ppat.1001144.g003
IL-22 Induced by Live B. burgdorferi
PLoS Pathogens | www.plospathogens.org 7 October 2010 | Volume 6 | Issue 10 | e1001144experiments in the current study. Since IL-17 and IL-22 are both
key to Th17-like biological activity [5,6], we set out to analyze IL-
22 under those same conditions. Surprisingly, B. burgdorferi
mediated robust and early IL-22 expression. In fact, mRNA
analysis revealed induction of IL-22 expression as early as 10 h
after onset of exposure to B. burgdorferi. Data were complemented
by immunohistochemical detection of IL-22 in skin biopsies
obtained from erythema chronicum migrans patients, though this
pathological status may barely reflect innate skin immunoactiva-
tion in the initial phase of infection.
A string of recent publications identified an apparently
heterogeneous group of human T cell subsets with the capability
to generate IL-22 but decisively not IL-17 [7,23–27]. These cells in
part belong to the memory CD4
+ T cell subset and have been
introduced as Th22 [23] or T22 cells [25]. The latter
nomenclature alludes to the fact that T cells fulfilling the
aforementioned criterion may display either CD4
+ or CD8
+
characteristics [25]. Only T cells and NK cells are regarded as
relevant sources of IL-22 in human PBMC. Thus, CD3
+/CD4
+/
CD8
+/CD56
+ depletion experiments suggest that CD3
+ T cells,
mainly CD4
+ but also CD8
+ T cells, were the principal source of
PBMC-derived IL-22 under the influence of B. burgdorferi.
Depletion experiments were complemented by PCR analysis
confirming spirochete-induced IL-22 expression in CD4
+ as well
as CD8
+ T cells. Notably, this alleged T22-type of cytokine
response is achieved herein without additional artificial co-
stimulatory signals such as anti-CD3/-CD28 treatment or harsh
exposure to PMA/ionomycin.
Early work indicated that antigens derived from B. burgdorferi are
in principle able to initiate activation and proliferation of human T
cells [62]. However, undetectable IL-2 production by PBMC
cultures even after 65 h of exposure to B. burgdorferi suggests that
antigenic stimulation via the T cell receptor should play a lesser
role in the present experimental setting.
Previous data on PBMC demonstrate that phagocytosis of B.
burgdorferi by monocytes mediates initial activation of innate
immunity with strong induction of pro-inflammatory cytokines,
including IL-1b, within 4 h–8 h of exposure [32,34,51]. In fact,
significantly increased tissue expression of IL-1b has been detected
previously in biopsy specimens obtained from erythema migrans
patients that displayed acute flu-like symptoms. Remarkably,
patients of this group, particularly in the U.S.A, are more likely to
exhibit hematogenous dissemination [30], possibly as a conse-
quence of fulminant infection and subsequent collateral tissue
Figure 4. T cell-dependent production of IL-22 by PBMC exposed to live B. burgdorferi. After isolation, PBMC were either depleted for CD3
+
(A) or CD56
+ (B) cells (see methods section). FACS analysis was performed by gating on lymphocytes in order to confirm successful manipulation of
PBMC. Representative depletion experiments are shown. Thereafter, whole PBMC and either CD3 (C) or CD56 (D) depleted cell populations were
exposed to B. burgdorferi 297 (MOI=0.1). After 65 h, release of IL-22 and IFNc was determined by ELISA. Data are expressed as means 6 SEM (CD3
depletion: n=5; CD56 depletion: n=8); n.s. denotes not significantly different from B. burgdorferi 297-stimulated whole PBMC; *p,0.05 compared
with B. burgdorferi 297-stimulated whole PBMC. Raw data were analyzed by unpaired Student`s t-test.
doi:10.1371/journal.ppat.1001144.g004
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IL-1b is almost exclusively achieved by monocytes which,
compared to macrophages, display less tight control of caspase-1
activity. Dermal tissue macrophages are obviously among the first
cell types to be activated at initial infection by B. burgdorferi.
Notably, induction and processing of pro-IL-1b by caspase-1 in
dermal tissue macrophages is supposed to be achieved by a two-hit
action of spirochetes delivering pathogen associated molecular
patterns for activation of sensors of innate immunity along with
activation of the purinoceptor P2X7 via extracellular ATP. In fact,
Figure 5. IL-22 expression by PBMC exposed to live B. burgdorferi is dependent on both, CD4
+ and CD8
+ T cells. After isolation, PBMC
were either depleted for CD4
+ (A) or CD8
+ (B) cells (see methodssection). FACS analysis was performed by gating on lymphocytes in order to confirm
successful manipulation of PBMC. Representative depletion experiments are shown. (C) Thereafter, whole PBMC and either CD4 or CD8 depleted cell
populations were kept as unstimulated control or exposed to B. burgdorferi 297 (MOI=0.1). After 65 h, release of IL-22 was determined by ELISA. Data
are expressed as means 6 SEM (n=3); ***p,0.001 compared with unstimulated whole PBMC; ## p, 0.01, ### p,0.001 compared with whole
PBMC exposed to B. burgdorferi 297. Raw data were analyzed by one-way ANOVA with post hoc Bonferroni correction. (D) PBMC from three different
donors were either kept as unstimulated control or were exposed to B. burgdorferi 297 (MOI=0.1). After 24 h, CD4
+ and CD8
+ T cells were isolated as
outlined in the materials and methods section. After isolation of total RNA from either unfractionated PBMC and CD4
+ or CD8
+ T cells, IL-22 mRNA
expression was analyzed by standard PCR. Data from all three donors are shown.
doi:10.1371/journal.ppat.1001144.g005
IL-22 Induced by Live B. burgdorferi
PLoS Pathogens | www.plospathogens.org 9 October 2010 | Volume 6 | Issue 10 | e1001144upregulation of extracellular ATP has been observed in the
context of bacterial infections and secretion of processed IL-1b
[63,64] Thus, prerequisites for caspase-1 activation and IL-1b
processing/secretion in skin macrophages exposed to B. burgdorferi
are likely in place. Since IL-1b was among the cytokines found to
be most prominently upregulated by live spirochetes and this
cytokine has been linked to IL-22 production in the context of
Th17 activity [21], its impact on IL-22 production was assessed. In
fact, blockage of IL-1 biological activity by IL-1Ra or caspase-1
inhibition impaired secretion of IL-22 by PBMC exposed to B.
burgdorferi. CD14
+ depletion experiments furthermore demonstrat-
ed that monocytes are responsible for practically all IL-1b being
released by PBMC under the influence of B. burgdorferi. Moreover,
depletion was associated with a significant 59.6% reduction of IL-
22 release. These data indicate an important role of monocytes for
T cell activation and the IL-22 response of PBMC towards live B.
burgdorferi. On the other hand, data also suggest that about 40% of
IL-22 release is monocyte- and IL-1b-independent. pDC, proven
to enhance IL-22 production by isolated and PMA/ionomycin-
activated T cells [23], must be regarded important in that context.
However, activation of the pDC population in cultured PBMC by
incubation with two different (type A and type C) CpG
oligonucleotides failed to induce IL-22 herein. Those data agree
with a recent publication demonstrating that systemic application
of CpG oligonucleotides in mice fails to mediate IL-22 expression
in the spleen and, compared to e.g. the TLR5 ligand flagellin, only
moderately induces IL-22 in mesenteric lymph nodes [65]. In
addition, we observed that engagement of the TLR9/CpG axis
significantly impaired release of IL-22 from PBMC activated by B.
burgdorferi. However, it should be kept in mind that exposure of
pDC to CpG oligonucleotides is a cellular model but may not
necessarily echo internalization of live-spirochetes by pDC.
Notably, phagocytosis of B. burgdorferi by human DC has been
detected early on [66].
Figure 6. Production of IL-22 by PBMC exposed to live B. burgdorferi partially depends on intermediate monocyte activation. (A)
After isolation, PBMC were depleted for CD14
+ cells (see materials and methods section). FACS analysis was performed in order to confirm successful
manipulation of PBMC. Representative depletion experiments are shown. Thereafter, whole PBMC or CD14-depleted cell populations were exposed
to B. burgdorferi 297 (MOI=0.1). After 65 h, release of IL-1b (B), IFNc (C), and IL-22 (D) was determined by ELISA. Data are expressed as means 6 SEM
(n=5); n.s. denotes not significantly different from B. burgdorferi 297-stimulated whole PBMC; *p,0.05 compared with B. burgdorferi 297-stimulated
whole PBMC. Raw data were analyzed by unpaired Student`s t-test.
doi:10.1371/journal.ppat.1001144.g006
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stimulus is sufficient to mediate production of IL-22 but not of IL-
17 by PBMC. This observation may have broad implications for
diseases that respond to IL-1Ra treatment and have been
associated with a pathologic role of IL-22. For example, it is
tempting to speculate that therapeutic efficacy of IL-1Ra in some
rheumatoid arthritis patients [67,68] may in part be mediated by
ill-fated IL-1-induced IL-22 in these individuals [13,69].
Lack of early IL-17 in PBMC cultures highly activated by live
Borreliae was unexpected. A recent report demonstrates secretion of
IL-17 by naı ¨ve CD4
+ T cells without artificial TCR activation and
costimulatory signals but mediated by cocultivation with mono-
cyte-derived Langerhans cells or DC that had been pretreated
with peptidoglycan or Pam3CSK4 [70]. Both agents are known to
act via the toll-like receptor (TLR)-2 and TLR2 is supposed to be
one major sensor of B. burgdorferi [29]. Yet, previous reports clearly
demonstrate that use of B. burgdorferi lysates and likewise more
restricted TLR2 activation only poorly reflects PBMC and
monocyte activation by live B. burgdorferi [32,34]. Robust IL-17
production is also induced in PBMC by heat-inactivated Candida
albicans, again in the absence of additional artificial TCR
activation and costimulatory signals [71].
Quality and quantity of immediate innate immune responses is
supposed to shape the course of dermal infection by B. burgdorferi.
Specifically, expression of defined cytokine patterns may impact
on bacterial dissemination. In this context, early regulation of IL-
17 and IL-22 as detected herein is likely of significance. Vascular
permeability is a parameter that appears to play a key role in
bacterial dissemination [72]. Indeed, IL-22 has been shown to
increase vascular permeability [73], a function that may relate to
upregulation of matrix metalloproteinases [13,74–76] and iNOS
[17,77] under the influence of this cytokine. However, despite
some tendencies, there were no significant differences concerning
IL-22 induction between the Borrelia genospecies tested, irrespec-
tive of their potential clinical properties e.g. with regard to
dissemination. This observation may simply mirror the fact that
IL-22 is likely only one parameter among others affecting early
course of infection. On the contrary, IL-22 may actually restrain
bacterial growth and dissemination by its well-characterized
tissue protective and antibacterial properties [1,2]. Certainly,
this pathophysiologically important issue warrants further
attention.
A crucial characteristic of IL-17 biological activity is initiation of
neutrophilic inflammation [3]. Although activated neutrophils are
to some degree detectable in B. burgdorferi-associated erythema
migrans [31], gross infiltration by neutrophils is not a typical
histopathological characteristic of these lesions. In contrast, dermal
infiltrates are predominantly composed of lymphocytes and
Figure 7. Activation of pDC by CpG oligonucleotides does not associate with enhanced production of IL-22 by PBMC. PBMC were
either kept as unstimulated control, were exposed to B. burgdorferi 297 (MOI=0.1) or were activated by CpG oligonucleotides (10 mg/ml) type A (A) or
type C (B) alone or in the presence of B. burgdorferi 297 (MOI=0.1). After 65 h, release of IL-22 (left panel) and IFNa (right panel) was determined by
ELISA. Data are expressed as means 6 SEM (n=6); *p,0.05, ***p,0.001 compared with unstimulated control; ## p,0.01, ### p,0.001 compared
with B. burgdorferi 297 alone. Raw data were analyzed by one-way ANOVA with post hoc Bonferroni correction.
doi:10.1371/journal.ppat.1001144.g007
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ciently kill B. burgdorferi, especially when opsonized with antibodies
available subsequent to initial defense [78]. Increasing dermal
neutrophilic infiltration by experimental means in fact reduces
bacterial dissemination in acute murine B. burgdorferi infection [79].
Thus, current knowledge implies that insufficient neutrophil
recruitment/activation, possibly as a result of insufficient imme-
diate IL-17 production and lack of opsonizing antibodies, may
favor initial spread of B. burgdorferi. It must be emphasized at this
point that during B. burgdorferi-associated chronic immunoactiva-
tion IL-17 production certainly evolves. In fact, T helper cells
isolated from synovial fluid of Lyme arthritis patients produce IL-
17 after polyclonal ex vivo stimulation [80]. Notably, blockage of
IL-17 bioactivity ameliorates disease in murine Lyme arthritis
[81].
The tick-Borrelia-skin interface shows some characteristics
favoring a microenvironment that supports successful infection.
Of note are diverse strategies utilized by Borrelia that result in
impairment of host skin’s innate immunity. Those include
expression of CRASP proteins to impair complement-mediated
killing. In addition, tick saliva displays immunosuppressive
properties e.g. by its capability to decrease IL-8 and defensin
secretion from human keratinocytes [29,82–85]. Here we report
for the first time that human PBMC exposed to live B. burgdorferi,
despite being highly activated, lack initial IL-17 secretion. A recent
report suggests that protective properties of IL-22 at host/
environment interfaces are accentuated in the context of IL-17
deficiency [86]. In keeping with this line, it is tempting to speculate
that IL-22 may play a decisive role in early human B. burgdorferi
infection by supporting a balanced host defense along with tissue
protection.
Materials and Methods
Ethics statement
For isolation of PBMC blood was taken from healthy donors.
This procedure and the respective consent documents were
approved by the ‘Ethik Kommission’ of the University Hospital
Goethe-University Frankfurt (Gescha ¨fts-Nr.: 170/1998). All
healthy donors provided written informed consent.
Reagents
Human recombinant IL-2, IL-23, and IL-1Ra were purchased
from R&D Systems (Wiesbaden, Germany). Human IL-10 and
TNFa were from TEBU-BIO/Peprotech Inc. (Frankfurt, Ger-
many) and IL-1b was from Invitrogen/Biosource (Karlsruhe,
Germany). PmxB and dexamethasone were from Calbiochem-
Novabiochem GmbH (Bad Soden, Germany). Ac-YVAD-CHO
was from Bachem AG (Weil am Rhein, Germany). A type A
(ODN2219: ggGGGACGATCGTCgggggg) and a type C CpG
oligonucleotide (ODN2395: tcgtcgttttcggcgcgcgccg) were pur-
chased by InvivoGen (San Diego, USA).
Figure 8. Analysis of IL-22 expression in biopsy specimens obtained from erythema chronicum migrans patients. 7 out of 12 specimens
obtained from erythema chronicum migrans patients displayed abundant presence of IL-22 positive cells. Two of these skin biopsies are shown in two
magnifications.
doi:10.1371/journal.ppat.1001144.g008
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CSF isolate B. burgdorferi 297, CSF isolate B. garinii G1, skin
isolate B. spielmanii A14S, tick isolate B. lusitaniae MT-M8, CSF
isolate B. bavariensis PBi, and clonal skin isolate B. afzelii FEM-1
D15 were grown at 33uC for 4 days up to cell densities of
1610
7 ml
21 in modified Barbour-Stoenner-Kelly (BSK) medium
as described previously [87]. For stimulation of PBMC’s,
spirochetes grown to mid-log phase were harvested by centrifu-
gation (50006g; 30 min; 4uC) and washed twice in RPMI 1640
medium to remove bovine serum albumin and additional serum
constituents of the BSK medium. The bacterial sediments were
then resuspended in 500 ml of RPMI 1640 medium. Dark-field
microscopy was used to check viability and motility of the
spirochetes before the cells density was determined using a Kova
counting chamber (Hycor Biomedical, Garden Grove, CA). In
brief, an aliquot (10 ml) of the spirochetal suspension was diluted
1:1000 or 1:2000 in PBS. Ten microliters of the respective
dilutions were drawn into the slides resulting in a homogenous
distribution of the cells by capillary action. For calculation of the
cell density, ten square grids were counted by using the following
equation: cells/ml=average of cells per square grid690 (multipli-
cation factor) 6dilution as recommmend by the manufacturer.
Serological analysis of blood donors
Sera from blood donors were tested for the presence of anti-
Borrelia IgM and IgG antibodies using commercially available
ELISAs (Enzygnost Borreliosis/IgM and Enzygnost Lyme link
VlsE/IgG, Siemens Healthcare Diagnostics Products GmbH,
Marburg, Germany) as well as a line immunoblot (Mikrogen,
Neuried, Germany) in which p100, VlsE, p58, p41 (flagellin), p39,
OspA, OspC and p18 (DbpA) are included as target antigens. For
the two latter, four and five distinct OspC and p18 antigens
obtained from B. burgdorferi, B. afzelii, B. garinii, and B. spielmanii were
applied on the nitrocellulose membranes, respectively. Concerning
the detection of anti-Borrelia IgM antibodies, serum samples were
adsorbed using RF adsorbens prior to testing. Following the
recommendations of the manufacturer for sample preparation,
diluted sera were then analyzed automatically by the BEP III
system. Employing line immunoassays individual serum samples
were diluted 1:50 and 1:100 for the detection of anti-Borrelia IgM
and anti-Borrelia IgG antibodies, respectively. Binding of specific
antibodies was then detected by using peroxidate-conjugated goat
anti-human IgM or anti-human IgG serum (1:100).
Isolation and cultivation of human PBMC obtained from
healthy volunteers
Healthy donors had abstained from taking drugs for 2 weeks
prior to the study. Blood was used from 12 donors. Eleven donors
included in the study proved to be negative for IgM or IgG anti-
Borrelia antibodies. One donor died from a traffic accident during
the study and was not analyzed concerning this point. Notably,
experimental results of this donor were similar to the other 11
donors. PBMC were freshly isolated from peripheral blood using
Histopaque-1077 (Sigma-Aldrich, Taufkirchen, Germany) accord-
ing to the manufacturer’s instructions. For cultivation, PBMC were
routinely resuspended in RPMI 1640 (GlutaMAX) supplemented
with10 mMHEPESand1%humanserum (Invitrogen)andseeded
at 3610
6 cells/ml in round-bottom polypropylene tubes (Greiner,
Frickenhausen, Germany). Compared to other cell culture media
such as IMDM, RPMI 1640 contains a striking low amount of
aromatic amino acids which may serve as precursors for ligands of
the aryl hydrocarbon receptor (AhR) [88]. Notably, in the human
system, AhR ligands support production of IL-22 but inhibit that of
IL-17 [24]. Therefore, cultivation of human leukocytes in RPMI
1640 should technically promote IL-17 production.
Purification of human primary CD3
+ T cells and flow
cytometric quality control
PBMC were isolated from 6 healthy donors (50 ml peripheral
blood each) by density gradient centrifugation followed by T cell
purification using Human T Cell Enrichment Kit (EasySep
Negative Selection; StemCell Technologies, UK) and the EasySep
Magnet according to the manufacturers’ recommendations. Purity
of viable enriched T cells and the amount of residual accessory cell
populations were analyzed on a 5-color flow cytometer (FC500,
Beckman Coulter, Krefeld, Germany). Monoclonal antibodies
(Beckman Coulter, Marseille, France) against the following antigens
(clones) were used: CD3 (UCHT1), CD4 (SFCI12T4D11), CD8
(SFCI21Thy2D3), CD14 (RMO52), CD16 (3G8), CD19 (J4.119),
CD33 (D3HL60.251), CD45 (J.33), CD56 (N901), CD85k (ILT3,
clone ZM3.8) and CD123 (107D2) conjugated with fluorescein
isothiocyanate (FITC), phycoerythrin, (PE), phycoerythrin-Texas-
Red-Tandem (ECD), phycoerythrin-cyanin-5 (PC-5) or phycoery-
thrin-cyanin-7 (PC-7). For assessment of viability 7-AAD was used.
The panel combinations CD45/CD4/CD8/CD3/CD14 and
CD45/CD56/CD19/CD3/CD16 were performed for analyzing
the major leukocyte subpopulations in dual platform approach.
Measurements of the myeloid dendritic cells and plasmacytoid
dendritic cells were carried out in a single platform approach using
fluorescent microspheres (Flow-Count fluorospheres, Beckman
Coulter). T cell purification of the 6 different healthy donors
resulted in a range of 99.6% to 99.9% CD3+ viable T cells (median
purity: 99.8%) gated on CD45+ leukocytes. The remaining cells
belonged to a median of 0.02% CD56+CD3- NK cells and less than
0.001% and 0.004% for myeloid dendritic and plasmacytoid
dendritic cells, respectively. For both, CD19
+ B cells and CD14
+
monocytes no residual cells could be detected. After isolation,
purified CD3
+ T cells were cultured in the aforementioned PBMC
medium.
Depletion of CD3
+, CD56
+, CD4
+, CD8
+, and CD14
+ cells
from PBMC
CD3-, CD56-, CD4-, CD8-, or CD14-beads for depletion of
specific cell populations were used according to the manufacturer’s
instructions (Miltenyi, Bergisch Gladbach, Germany). Briefly,
1.5610
7 PBMC were used per column (without beads as control
and with specific beads) and were counted again after the
depletion procedure. Cells were resuspended in aforementioned
medium and seeded at 3610
6 cells/ml in round-bottom
polypropylene tubes. To assess successful depletion, FACS analysis
(either FACS Calibur or FACS Canto II, BD Biosciences,
Heidelberg, Germany) was performed with the following antibod-
ies: mouse monoclonal anti-human CD3-PerCP/Cy5.5 (Biozol,
Eching, Germany), CD56-FITC (eBioscience, Frankfurt, Ger-
many), CD4-PE-Cy7, CD8-Horizon (both BD Bioscience, Heidel-
berg, Germany), and CD14-PE (eBioscience, Frankfurt, Ger-
many). FACS data were analyzed by gating on lymphocytes (CD3,
CD56, CD4, CD8 depletion) or on total PBMC (CD14 depletion).
Isolation of CD4
+ and CD8
+ T cells from PBMC
CD4- or CD8-beads for subset isolation were used according to
the manufacturer’s instructions (Miltenyi). 2.4610
7 PBMC were
applied per column. To assess successful purification, FACS
analysis (FACS Canto II) was performed with the following
antibodies: mouse monoclonal anti-human CD3-PerCP/Cy5.5
(Biozol), CD4-PE-Cy7, and CD8-Horizon (BD Bioscience). FACS
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+,
94.9%62.4%; CD8
+, 97.3%61.0%; numbers include infrequent
CD4
+CD8
+ T cells [89]). Subsequent isolation of total RNA and
analysis for IL-22 mRNA expression by standard PCR was
performed as described below.
Cultivation of Jurkat T cells
Human Jurkat T cells were obtained from the German
Collection of Microorganisms and Cell Cultures (Braunschweig,
Germany). For maintainance Jurkat T cells were cultured in
RPMI 1640 supplemented with 100 U/ml penicillin, 100 mg/ml
streptomycin, and 10% heat-inactivated FCS (GIBCO-BRL,
Eggenstein, Germany). For experiments with conditioned media
Jurkat T cells were seeded on 6-well polystyrene plates (Greiner) at
a density of 2.56106 cells/ml.
Cloning of the human IL-22 promotor, transient
transfection of Jurkat T cells, and luciferase reporter assays
Using genomic DNA isolated from human THP-1 cells we
amplified the 59 flanking region of the IL-22 gene by pfu
polymerase (Invitrogen). For that purpose the following primers
generating a 1230 bp promotor fragment (excluding an additional
flanking BglII or HindIII cloning/restriction site) were used:
forward, 59-CAATAGGTATTTGCATTTTGAT-AC-39 and re-
verse, 59-TGCAGACAATTCTAACTCGAG-39. This promotor
fragment ends 59 adjacent to the adenine nucleotide of the IL-22
translational start site. After cloning into pGL3-Basic (Promega,
Mannheim, Germany) and sequencing (Seqlab, Go ¨ttingen,
Germany) this plasmid (pGL3-IL22) was transiently transfected
into Jurkat T cells using DMRIE-C reagent (Invitrogen). For each
reaction 4 mg of pGL3-IL22 were transfected into 2.5610
6 Jurkat
T cells according to the manufacturer `s instructions. 0.1 mg pRL-
TK (Promega) coding for Renilla luciferase were cotransfected.
After 5 h of transfection and medium change, cells were rested for
15 h. Thereafter, cells were resuspended in conditioned medium.
Conditioned media for resuspension of Jurkat T cells were
obtained either from unstimulated PBMC (CCM) or from PBMC
exposured for 15 h to B. burgdorferi 297 at the indicated MOI. After
resuspension, Jurkat T cells were stimulated where indicated by an
mouse anti-human CD3 antibody (25 mg/ml, eBioscience). After
8 h, cells were harvested and luciferase activity was determined
using the dual reporter gene system (Promega) and an automated
chemiluminescence detector (Berthold, Bad Wildbad, Germany).
Detection of IL-22 mRNA by standard and realtime PCR
Total RNA was isolated using TRI-Reagent (Sigma-Aldrich)
and transcribed using random hexameric primers and Moloney
virus reverse transcriptase (Applied Biosystems, Weiterstadt,
Germany). The following sequences were performed for standard
PCR: 94uC for 10 min (1 cycle); 94uC for 1 min, 60uC (GAPDH),
58uC (IL-22) for 30 sec, and 72uC for 45 sec (with the indicated
numbers of cycles); final extension phase at 72uC for 7 min.
Primer sequences and length of resulting amplicons: GAPDH (F):
59-ACCACAGTCCATGCCA-TCAC-39, GAPDH (R): 59-TCC-
ACCACCCTGTTGCTGTA-39, 452 bp, 24 cycles; IL-22 (F): 59-
GCTAAGGAGGCTAGCTTG-39, IL-22 (R): 59-CAGCAAATC-
CAGTTCTCC-39, 299 bp, 38 cycles. Identity of amplicons was
confirmed by sequencing (310 Genetic Analyzer, Applied
Biosystems). During realtime PCR, changes in fluorescence were
caused by the Taq-polymerase degrading the probe that contains a
fluorescent dye (FAM used for IL-22, VIC for GAPDH) and a
quencher (TAMRA). For IL-22 (#Hs00220924_m1) and GAPDH
(#4310884E) pre-developed assay reagents were obtained
(Applied Biosystems). Assay-mix was used from Invitrogen.
Realtime PCR was performed on AbiPrism 7500 Fast Sequence
Detector (Applied Biosystems): One initial step at 95uC for 5 min
was followed by 45 cycles at 95uC for 2 seconds and 60uC for 25
seconds. Detection of the dequenched probe, calculation of
threshold cycles (Ct values), and data analysis were performed
by the Sequence Detector software. Relative changes in IL-22
mRNA expression compared to unstimulated control and
normalized to GAPDH were quantified by the 2
-ddCt method.
Cytokine profiling by antibody array analysis
Human Cytokine Array Panel A Kit (R&D Systems) was used
for analysis according to the manufacturer `s instructions. PBMC
were either kept as unstimulated control or exposed to live B.
burgdorferi 297 (MOI=0.1). After 65 h, analysis was performed by
using supernatants in a 1:3 dilution. Signals were detected by a
chemoluminescence detection kit (GE Healthcare, Freiburg,
Germany) according to manufacturer’s instructions. Semiquanti-
tative analysis were performed by using Quantity One software
(Biorad, Munich, Germany).
Analysis of cytokine release by emzyme-linked
immunosorbent assay (ELISA)
Concentrations of IL-8, IFNc, and TNFa, (Pharmingen/BD
Biosciences), IL-1b, IL-17A (denoted IL-17 throughout the
manuscript), IL-22, IL-23, and IL-18 (R&D Systems/MBL), IFNa
(BenderMed Systems, Vienna, Austria), as well as IL-2, IL-10, IL-
17F, and IL12p70 (eBioscience) in cell-free cell culture superna-
tants were determined by ELISA according to the manufacturers’
instructions.
Immunohistochemical detection of IL-22 in tissue
sections obtained from erythema chronicum migrans
patients
Ready-to-use tissue sections (Dermatopathological Laboratory
Offenbach) obtained from lesions of patients diagnosed for erythema
chronicum migrans after a tick bite were immunohistochemically
analyzed. Biopsy specimens were taken a few weeks after the initial
tick bite. Four-micrometer sections of formalin-fixed, paraffin-
embedded skin lesion from erythema migrans patients were used for
detection of cutaneous cells producing IL-22. Briefly, sections were
deparaffinized and unmasked by heat treatment (Dako Cytoma-
tion Target Retrieval Solution). Thereafter, sections were
incubated with rabbit anti-human IL-22 polyclonal antibody
(Abcam, Cambridge, UK) overnight at 4uC. Biotinylated-goat
anti-rabbit antibody and the avidin-biotin-peroxidase complex
(ABC-system, Santa Cruz) and 3,3-diaminobenzidine-tetra-hydro-
chloride pellets (Sigma-Aldrich) were used for detection.
Statistical analysis
Data are shown as means 6 SEM (PBMC) or means 6 SD
(Jurkat T cells) and are presented as pg/ml, ng/ml, fold-induction,
(% of aCD3 at CCM), (% of CCM), or (% of B. burgdorferi alone).
Statistical analysis was performed either by unpaired Students t-
test or one-way ANOVA with post-hoc Bonferroni correction as
indicated in the legends (GraphPad 5.0).
Supporting Information
Figure S1 B. burgdorferi 297-induced cytokine expression as
detected by antibody array analysis. Antibody array overview.
Found at: doi:10.1371/journal.ppat.1001144.s001 (0.04 MB
DOC)
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Found at: doi:10.1371/journal.ppat.1001144.s002 (0.29 MB TIF)
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